Strategies to Improve the Effect of Vaccination in the Elderly: the Vaccine Producer's Perspective

被引:0
作者
Guy, B. [1 ]
机构
[1] Sanofi Pasteur, F-69280 Marcy Letoile, France
关键词
adjuvant; elderly people; vaccination; INFLUENZA VACCINE; T-CELLS; IN-VIVO; OLD-AGE; IMMUNOGENICITY; RESPONSES; ADJUVANT; IMMUNITY; ADULTS; YOUNG;
D O I
10.1016/j.jepa.2009.09.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The weakened immune system of elderly people presents particular challenges in the development of vaccines and caccination strategies for this population. There are well recognized changes in the function of antigen presenting cells (APCs), T cells and B cells in older people. A further means of enhanceing antigen presentation and subsequent T-cell activation would be to increase the vaccination at an earlier age may trigger naive T cells and subsequent generation of memory cells more efficiently and these cells may be recalled more easily in later life. Finally, the use of polysaccharide-protein conjugates might enhance the level and functionality of antibodies directed against polysaccharides. These different possibilities, alone or in combination, could improve caccine efficacy in elderly human populations. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S133 / S137
页数:5
相关论文
共 50 条
  • [41] COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness
    Roozen, Geert V. T.
    Roukens, Anna H. E.
    Roestenberg, Meta
    LANCET GLOBAL HEALTH, 2022, 10 (04): : E570 - E573
  • [42] Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine
    Sullivan, Seth J.
    Jacobson, Robert
    Poland, Gregory A.
    EXPERT REVIEW OF VACCINES, 2010, 9 (10) : 1127 - 1133
  • [43] Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+and CD8+T Cell Phenotypes to Improve the Antitumor Therapeutic Effect
    Hofer, Tamara
    Rossi, Matteo
    Carboni, Susanna
    Di Berardino Besson, Wilma
    von Laer, Dorothee
    Wollmann, Guido
    Derouazi, Madiha
    Santiago-Raber, Marie-Laure
    CANCERS, 2021, 13 (23)
  • [44] Vaccination and immunization strategies to design Aedes aegypti salivary protein based subunit vaccine tackling Flavivirus infection
    Pandey, Rajan Kumar
    Dahiya, Surbhi
    Mahita, Jarjapu
    Sowdhamini, Ramanathan
    Prajapati, Vijay Kumar
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 122 : 1203 - 1211
  • [45] The effect of zinc sulfate on immunologic response to recombinant hepatitis B vaccine in elderly
    Afsharian, Mandana
    Vaziri, Siavash
    Janbakhsh, Ali Reza
    Sayad, Babak
    Mansouri, Feizollah
    Nourbakhsh, Javad
    Qadiri, Keyghobad
    Najafi, Farid
    Shirvanii, Maria
    HEPATITIS MONTHLY, 2011, 11 (01) : 33 - 36
  • [46] COVID 19 Vaccination strategies in India- A Public Health perspective
    Priyanka
    Arora, Ekta
    Debbarma, Shibajee
    Rasania, Sanjeev Kumar
    INDIAN JOURNAL OF COMMUNITY HEALTH, 2021, 33 (04) : 668 - 670
  • [47] Optimal COVID-19 Vaccination Strategies with Limited Vaccine and Delivery Capabilities
    Santini S.
    ACM Transactions on Computing for Healthcare, 2021, 2 (04):
  • [48] Interdisciplinary symposium on challenges and opportunities for vaccines: A comprehensive approach of current and future vaccine strategies to improve vaccine effectiveness in complex chronic infectious contexts
    Siebner, Alex S.
    Habib, Marrium
    Osmani, Vanesa
    Adegnika, Ayola Akim
    Bogdan, Christian
    Breloer, Minka
    Elliott, Alison
    Fathik, Anahita
    Hendrickx, Greet
    Nono, Justin Komguep
    Lang, Roland
    Mayer, Johannes U.
    Mordmueller, Benjamin
    Ndungo, Esther
    Protzer, Ulrike
    Yazdanbakhsh, Maria
    Klug, Stefanie J.
    da Costa, Clarissa Prazeres
    Esen, Meral
    VACCINE: X, 2025, 23
  • [49] Optimizing RTS,S Vaccination Strategies: Give It Your Best Parting Shot
    McCall, Matthew B. B.
    Yap, Xi Zen
    Bousema, Teun
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (10) : 1581 - 1584
  • [50] Enhancing vaccine clinical trials participation among elderly: challenges and strategies
    Gillard, Paul
    Nakhle, Samer
    Brimhall, Darin
    Henry, Ouzama
    Mesaros, Narcisa
    TRIALS, 2025, 26 (01)